FITZGERALD EDWARD M bought PBLS
June 11, 2026 · Form 4 insider transaction
FITZGERALD EDWARD M bought 5,332 shares of Parabilis Medicines, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,332
Price
N/A
Total value
N/A
InsiderFITZGERALD EDWARD M
RoleDirector
SecuritySeries B Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateJune 11, 2026
Filing dateJune 15, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series B Preferred Stock was convertible into Common Stock on a 1 to 1.0389 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on June 9, 2026 (the "IPO"). The Series B Preferred Stock had no expiration date.